INVESTIGATING THE IMPACT OF VARIOUS TKI DRUGS ON ABSORBED RADIATION DOSE


Toker O., Eminoğlu H. F., Özşahin Toker M., Demir M., İçelli O.

Turkish Physical Society 40th International Physics Congress, Muğla, Türkiye, 2 - 06 Eylül 2024, ss.310, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Muğla
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.310
  • İstanbul Üniversitesi Adresli: Evet

Özet

The primary objective of this study is to investigate the relation between Tyrosine

Kinase Inhibitors and dose enhancement factors (DEF). The Monte Carlo N-Particle

(MCNP) Transport Code version 6.2 was employed to simulate the interactions of

photons with TKIs across a range of energy levels. Through MCNP, detailed

evaluations of photon transport, dose deposition, and interaction probabilities within

thyroid tumors were conducted. This computational method offered valuable

insights into how various photon energies and TKI types affect DEF, which is

essential for optimizing radiotherapy outcomes. Although the simulations provided

robust models of photon interactions, they may not fully capture the complexities of

biological systems. Challenges such as variable drug distribution within patients and

tumor heterogeneity must be considered when applying simulation results to clinical

scenarios. Future research should focus on validating these findings through clinical

trials and refining dosimetric models to incorporate patient-specific variables. By

clarifying the interactions between TKIs and radiotherapy, subsequent studies could

advance personalized treatment strategies, ultimately improving outcomes for

patients with thyroid cancer.